Tokyo - Delayed Quote JPY

Terumo Corporation (4543.T)

Compare
2,991.00
-1.00
(-0.03%)
At close: 3:45:00 PM GMT+9
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
921,863,000.00
921,863,000.00
820,209,000.00
703,303,000.00
613,842,000.00
Cost of Revenue
442,688,000.00
442,688,000.00
402,839,000.00
333,962,000.00
287,219,000.00
Gross Profit
479,174,000.00
479,174,000.00
417,369,000.00
369,341,000.00
326,623,000.00
Operating Expense
339,079,000.00
339,079,000.00
300,036,000.00
253,381,000.00
228,237,000.00
Operating Income
140,095,000.00
140,095,000.00
117,333,000.00
115,960,000.00
98,386,000.00
Net Non Operating Interest Income Expense
754,000.00
754,000.00
-1,367,000.00
-1,899,000.00
-610,000.00
Pretax Income
140,829,000.00
140,829,000.00
116,137,000.00
114,501,000.00
97,060,000.00
Tax Provision
34,455,000.00
34,455,000.00
26,811,000.00
25,687,000.00
19,859,000.00
Net Income Common Stockholders
106,374,000.00
106,374,000.00
89,325,000.00
88,813,000.00
77,268,000.00
Diluted NI Available to Com Stockholders
106,374,000.00
106,374,000.00
89,325,000.00
88,813,000.00
77,268,000.00
Basic EPS
71.50
71.50
59.50
58.73
51.16
Diluted EPS
71.47
71.47
59.48
58.69
51.05
Basic Average Shares
1,487,842.00
1,487,842.00
1,501,229.02
1,512,418.10
1,510,195.70
Diluted Average Shares
1,488,403.42
1,488,403.42
1,501,871.05
1,513,321.85
1,513,526.36
Total Operating Income as Reported
140,096,000.00
140,096,000.00
117,332,000.00
115,960,000.00
98,386,000.00
Total Expenses
781,767,000.00
781,767,000.00
702,875,000.00
587,343,000.00
515,456,000.00
Net Income from Continuing & Discontinued Operation
106,374,000.00
106,374,000.00
89,325,000.00
88,813,000.00
77,268,000.00
Normalized Income
106,374,000.00
106,374,000.00
89,325,000.00
88,813,000.00
77,268,000.00
Interest Income
3,529,000.00
3,529,000.00
2,649,000.00
1,062,000.00
1,727,000.00
Interest Expense
2,775,000.00
2,775,000.00
4,016,000.00
2,961,000.00
2,337,000.00
Net Interest Income
754,000.00
754,000.00
-1,367,000.00
-1,899,000.00
-610,000.00
EBIT
143,604,000.00
143,604,000.00
120,153,000.00
117,462,000.00
99,397,000.00
EBITDA
220,349,000.00
220,349,000.00
190,391,000.00
176,344,000.00
153,329,000.00
Reconciled Cost of Revenue
442,688,000.00
442,688,000.00
402,839,000.00
333,962,000.00
287,219,000.00
Reconciled Depreciation
76,745,000.00
76,745,000.00
70,238,000.00
58,882,000.00
53,932,000.00
Net Income from Continuing Operation Net Minority Interest
106,374,000.00
106,374,000.00
89,325,000.00
88,813,000.00
77,268,000.00
Normalized EBITDA
220,349,000.00
220,349,000.00
190,391,000.00
176,344,000.00
153,329,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
3/31/2021 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

7733.T Olympus Corporation
2,344.00
+1.12%
 
8086.T Nipro Corporation
1,460.50
-1.05%
 
300888.SZ Winner Medical Co., Ltd.
39.55
+5.41%
 
7741.T HOYA Corporation
20,260.00
-0.66%
 
6869.T Sysmex Corporation
2,943.50
+1.08%
 
MMSI Merit Medical Systems, Inc.
99.89
+4.44%
 
LMAT LeMaitre Vascular, Inc.
95.85
+1.78%
 
STVN Stevanato Group S.p.A.
21.65
-1.23%
 
RGEN Repligen Corporation
156.55
-1.19%
 
AFX.DE Carl Zeiss Meditec AG
44.90
-3.69%